411 related articles for article (PubMed ID: 21322080)
1. Novel head and neck cancer survival analysis approach: random survival forests versus Cox proportional hazards regression.
Datema FR; Moya A; Krause P; Bäck T; Willmes L; Langeveld T; Baatenburg de Jong RJ; Blom HM
Head Neck; 2012 Jan; 34(1):50-8. PubMed ID: 21322080
[TBL] [Abstract][Full Text] [Related]
2. Impact of comorbidity on short-term mortality and overall survival of head and neck cancer patients.
Datema FR; Ferrier MB; van der Schroeff MP; Baatenburg de Jong RJ
Head Neck; 2010 Jun; 32(6):728-36. PubMed ID: 19827120
[TBL] [Abstract][Full Text] [Related]
3. Using the TNM system to predict survival in squamous cell carcinoma of the head and neck.
Hall SF; Groome PA; Rothwell D; Dixon PF
Anticancer Res; 1998; 18(6B):4777-8. PubMed ID: 9891556
[TBL] [Abstract][Full Text] [Related]
4. Does N stage predict survival?
Hall SF; Groome PA; Dixon PF
J Otolaryngol; 1996 Oct; 25(5):296-9. PubMed ID: 8902686
[TBL] [Abstract][Full Text] [Related]
5. Prediction of survival in patients with head and neck cancer.
Baatenburg de Jong RJ; Hermans J; Molenaar J; Briaire JJ; le Cessie S
Head Neck; 2001 Sep; 23(9):718-24. PubMed ID: 11505480
[TBL] [Abstract][Full Text] [Related]
6. Validation of the histologic risk model in a new cohort of patients with head and neck squamous cell carcinoma.
Brandwein-Gensler M; Smith RV; Wang B; Penner C; Theilken A; Broughel D; Schiff B; Owen RP; Smith J; Sarta C; Hebert T; Nason R; Ramer M; DeLacure M; Hirsch D; Myssiorek D; Heller K; Prystowsky M; Schlecht NF; Negassa A
Am J Surg Pathol; 2010 May; 34(5):676-88. PubMed ID: 20414102
[TBL] [Abstract][Full Text] [Related]
7. Prognostic variables and prognostic groups for malignant melanoma. The information from Cox and Classification And Regression Trees analysis: an Italian population-based study.
Crocetti E; Mangone L; Lo Scocco G; Carli P
Melanoma Res; 2006 Oct; 16(5):429-33. PubMed ID: 17013092
[TBL] [Abstract][Full Text] [Related]
8. Comorbidity measurement in patients with laryngeal squamous cell carcinoma.
Castro MA; Dedivitis RA; Ribeiro KC
ORL J Otorhinolaryngol Relat Spec; 2007; 69(3):146-52. PubMed ID: 17264530
[TBL] [Abstract][Full Text] [Related]
9. Impact of nutrition support on treatment outcome in patients with locally advanced head and neck squamous cell cancer treated with definitive radiotherapy: a secondary analysis of RTOG trial 90-03.
Rabinovitch R; Grant B; Berkey BA; Raben D; Ang KK; Fu KK; Cooper JS;
Head Neck; 2006 Apr; 28(4):287-96. PubMed ID: 16287132
[TBL] [Abstract][Full Text] [Related]
10. Matched analysis of survival in patients with squamous cell carcinoma of the head and neck diagnosed before and after 40 years of age.
Pytynia KB; Grant JR; Etzel CJ; Roberts D; Wei Q; Sturgis EM
Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):869-73. PubMed ID: 15262765
[TBL] [Abstract][Full Text] [Related]
11. Does TANIS (T And N Integer Score) help predict survival?
Hall SF; Groome PA; Dixon PF
J Otolaryngol; 1997 Feb; 26(1):8-12. PubMed ID: 9055167
[TBL] [Abstract][Full Text] [Related]
12. Risk-group definition by recursive partitioning analysis of patients with squamous cell head and neck carcinoma treated with surgery and postoperative radiotherapy.
Langendijk JA; Slotman BJ; van der Waal I; Doornaert P; Berkof J; Leemans CR
Cancer; 2005 Oct; 104(7):1408-17. PubMed ID: 16130134
[TBL] [Abstract][Full Text] [Related]
13. Soft-tissue sarcomas of the head and neck: a retrospective analysis of the Alberta experience 1974 to 1999.
Huber GF; Matthews TW; Dort JC
Laryngoscope; 2006 May; 116(5):780-5. PubMed ID: 16652087
[TBL] [Abstract][Full Text] [Related]
14. Impact of severe malnutrition on short-term mortality and overall survival in head and neck cancer.
Datema FR; Ferrier MB; Baatenburg de Jong RJ
Oral Oncol; 2011 Sep; 47(9):910-4. PubMed ID: 21802345
[TBL] [Abstract][Full Text] [Related]
15. The incidence and impact of comorbidity diagnosed after the onset of head and neck cancer.
Yung KC; Piccirillo JF
Arch Otolaryngol Head Neck Surg; 2008 Oct; 134(10):1045-9. PubMed ID: 18936348
[TBL] [Abstract][Full Text] [Related]
16. Importance of comorbidity in head and neck cancer.
Piccirillo JF
Laryngoscope; 2000 Apr; 110(4):593-602. PubMed ID: 10764003
[TBL] [Abstract][Full Text] [Related]
17. Correlation of numerical aberrations of chromosomes X and 11 and poor prognosis in squamous cell carcinomas of the head and neck.
Xie X; Clausen OP; Boysen M
Arch Otolaryngol Head Neck Surg; 2006 May; 132(5):511-5. PubMed ID: 16702567
[TBL] [Abstract][Full Text] [Related]
18. [The ASA-score as a comorbidity index in patients with cancer of the oral cavity and oropharynx].
Riechelmann H; Neagos A; Netzer-Yilmaz U; Gronau S; Scheithauer M; Rockemann MG
Laryngorhinootologie; 2006 Feb; 85(2):99-104. PubMed ID: 16498538
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-6 predicts recurrence and survival among head and neck cancer patients.
Duffy SA; Taylor JM; Terrell JE; Islam M; Li Y; Fowler KE; Wolf GT; Teknos TN
Cancer; 2008 Aug; 113(4):750-7. PubMed ID: 18536030
[TBL] [Abstract][Full Text] [Related]
20. Update and external validation of a head and neck cancer prognostic model.
Datema FR; Ferrier MB; Vergouwe Y; Moya A; Molenaar J; Piccirillo JF; Baatenburg de Jong RJ
Head Neck; 2013 Sep; 35(9):1232-7. PubMed ID: 22847987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
